Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

But almost as quickly as it burst onto the global market, semaglutide became difficult to get. Just months after the June 2021 approval of Wegovy, the version of the drug that's intended to treat ...

The Food and Drug Administration (FDA) has approved both Ozempic and Wegovy (semaglutide) to lower blood sugar, improve heart health, and support weight loss. Some differences set Ozempic and ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic ...